ArticleOPEN ACCESS

Correction to: Targeting the incretin system in obesity and type 2 diabetes mellitus (Nature Reviews Endocrinology, (2024), 20, 8, (447-459), 10.1038/s41574-024-00979-9)

Nature Reviews Endocrinology
DOI: 10.1038/s41574-024-00997-7
4Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Correction to: Nature Reviews Endocrinologyhttps://doi.org/10.1038/s41574-024-00979-9, published online 17 April 2024 In the version of the article initially published, in the “GLP1RAs and cardiorenal risk” section, the sentence now reading “A dedicated trial studying the effects of weekly 1 mg semaglutide on renal outcomes …” originally read “2.4 mg semaglutide” and has now been amended in the HTML and PDF versions of the article.

Cite

CITATION STYLE

APA

Ansari, S., Khoo, B., & Tan, T. (2024, August 1). Correction to: Targeting the incretin system in obesity and type 2 diabetes mellitus (Nature Reviews Endocrinology, (2024), 20, 8, (447-459), 10.1038/s41574-024-00979-9). Nature Reviews Endocrinology. Nature Research. https://doi.org/10.1038/s41574-024-00997-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free